Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/679425


Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012


Description: Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for key information and data relating to the Global diabetes care devices market. The report provides overview of key trends, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the Global diabetes care devices market. It also offers global and country level, detailed and comprehensive coverage of market revenue, volume, distribution and company share information.

Scope

- This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil) data on market size by volume and value for categories in diabetes care devices market.
- It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global, regional and country level.
- It also provides overview of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.
- All figures are based on rigorous research methodologies including in-depth primary and secondary research.


Reasons to buy

- A single source to fulfill all of your business and competitor intelligence needs
- Gain a strong understanding of the hospital supplies devices market at a global level, with break downs for 12 countries
- Evaluate and compare the attractiveness of the market in different geographies.
- Identify growth segments and opportunities in the industry.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched.
- Analyze the competitiveness of the market in different countries and regions and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
- Identify and analyze the strengths and weaknesses of the industry incumbents.


Contents: 1
1 2
1.1 List of Tables 8
1.2 List of Figures 14
2 Introduction 19
2.1 What Is This Report About? 19
3 Definitions of the Markets Covered in the Report 20
3.1 Diabetes Care Devices 20
3.2 Glucose Monitoring 20
3.3 Insulin Delivery 20
4 Global Diabetes Care Devices 21
4.1 Global Diabetes Care Devices, Overall Revenues ($ mn), 2000-2012 21
4.2 Global Diabetes Care Devices, Category Volume (Units), 2000-2012 25
4.3 Global Diabetes Care Devices, Company Share (2006-2007) 28
5 Diabetes Care Devices Cross Country Comparison 29
5.1 Diabetes Care Devices Cross Country Comparison (2000-2012) 29
6 Diabetes Care Devices in United States 30
6.1 Diabetes Care Devices, United States, Overall Revenues ($ mn), 2000-2012 30
6.2 Diabetes Care Devices, United States, Category Volume (Units), 2000-2012 34
6.3 Diabetes Care Devices, United States, Distribution Share (2006-2007) 37
6.4 Diabetes Care Devices, United States, Company Share (2006-2007) 38
7 Diabetes Care Devices in Canada 41
7.1 Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012 41
7.2 Diabetes Care Devices, Canada, Category Volume (Units), 2000-2012 45
7.3 Diabetes Care Devices, Canada, Distribution Share (2006-2007) 48
7.4 Diabetes Care Devices, Canada, Company Share (2006-2007) 49
8 Diabetes Care Devices in Germany 52
8.1 Diabetes Care Devices, Germany, Overall Revenues ($ mn), 2000-2012 52
8.2 Diabetes Care Devices, Germany, Category Volume (Units), 2000-2012 56
8.3 Diabetes Care Devices, Germany, Distribution Share (2006-2007) 59
8.4 Diabetes Care Devices, Germany, Company Share (2006-2007) 60
9 Diabetes Care Devices in France 63
9.1 Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012 63
9.2 Diabetes Care Devices, France, Category Volume (Units), 2000-2012 67
9.3 Diabetes Care Devices, France, Distribution Share (2006-2007) 70
9.4 Diabetes Care Devices, France, Company Share (2006-2007) 71
10 Diabetes Care Devices in United Kingdom 74
10.1 Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 74
10.2 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2012 78
10.3 Diabetes Care Devices, United Kingdom, Distribution Share (2006-2007) 81
10.4 Diabetes Care Devices, United Kingdom, Company Share (2006-2007) 82
11 Diabetes Care Devices in Italy 85
11.1 Diabetes Care Devices, Italy, Overall Revenues ($ mn), 2000-2012 85
11.2 Diabetes Care Devices, Italy, Category Volume (Units), 2000-2012 89
11.3 Diabetes Care Devices, Italy, Distribution Share (2006-2007) 92
11.4 Diabetes Care Devices, Italy, Company Share (2006-2007) 93
12 Diabetes Care Devices in Spain 96
12.1 Diabetes Care Devices, Spain, Overall Revenues ($ mn), 2000-2012 96
12.2 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2012 100
12.3 Diabetes Care Devices, Spain, Distribution Share (2006-2007) 103
12.4 Diabetes Care Devices, Spain, Company Share (2006-2007) 104
13 Diabetes Care Devices in Japan 107
13.1 Diabetes Care Devices, Japan, Overall Revenues ($ mn), 2000-2012 107
13.2 Diabetes Care Devices, Japan, Category Volume (Units), 2000-2012 111
13.3 Diabetes Care Devices, Japan, Distribution Share (2006-2007) 114
13.4 Diabetes Care Devices, Japan, Company Share (2006-2007) 115
14 Diabetes Care Devices in China 118
14.1 Diabetes Care Devices, China, Overall Revenues ($ mn), 2000-2012 118
14.2 Diabetes Care Devices, China, Category Volume (Units), 2000-2012 122
14.3 Diabetes Care Devices, China, Distribution Share (2006-2007) 125
14.4 Diabetes Care Devices, China, Company Share (2006-2007) 126
15 Diabetes Care Devices in India 129
15.1 Diabetes Care Devices, India, Overall Revenues ($ mn), 2000-2012 129
15.2 Diabetes Care Devices, India, Category Volume (Units), 2000-2012 133
15.3 Diabetes Care Devices, India, Distribution Share (2006-2007) 136
15.4 Diabetes Care Devices, India, Company Share (2006-2007) 137
16 Diabetes Care Devices in Australia 140
16.1 Diabetes Care Devices, Australia, Overall Revenues ($ mn), 2000-2012 140
16.2 Diabetes Care Devices, Australia, Category Volume (Units), 2000-2012 144
16.3 Diabetes Care Devices, Australia, Distribution Share (2006-2007) 147
16.4 Diabetes Care Devices, Australia, Company Share (2006-2007) 148
17 Diabetes Care Devices in Brazil 151
17.1 Diabetes Care Devices, Brazil, Overall Revenues ($ mn), 2000-2012 151
17.2 Diabetes Care Devices, Brazil, Category Volume (Units), 2000-2012 155
17.3 Diabetes Care Devices, Brazil, Distribution Share (2006-2007) 158
17.4 Diabetes Care Devices, Brazil, Company Share (2006-2007) 159
18 F. Hoffmann-La Roche Ltd. Company Profile 162
18.1 Company Overview 162
18.2 Value Chain Analysis 162
19 LifeScan, Inc. Company Profile 165
19.1 Company Overview 165
20 Abbott Laboratories Company Profile 167
20.1 Company Overview 167
20.2 Value Chain Analysis 167
21 Novo Nordisk A/S Company Profile 171
21.1 Company Overview 171
22 Bayer HealthCare AG Company Profile 173
22.1 Company Overview 173
22.2 Value Chain Analysis 173
22.3 Bayer HealthCare AG Pipeline Products 175
23 Eli Lilly and Company Company Profile 177
23.1 Company Overview 177
23.2 Value Chain Analysis 177
24 Medtronic, Inc. Company Profile 181
24.1 Company Overview 181
24.2 Value Chain Analysis 181
24.3 Medtronic, Inc. Pipeline Products 183
25 Becton, Dickinson and Company Company Profile 191
25.1 Company Overview 191
25.2 Value Chain Analysis 191
26 ARKRAY, Inc. Company Profile 193
26.1 Company Overview 193
27 Terumo Corporation Company Profile 194
27.1 Company Overview 194
27.2 Value Chain Analysis 194
27.3 Terumo Corporation Pipeline Products 196
28 AgaMatrix, Inc. Company Profile 198
28.1 Company Overview 198
29 Animas Corporation Company Profile 199
29.1 Company Overview 199
30 B. Braun Melsungen AG Company Profile 200
30.1 Company Overview 200
30.2 Value Chain Analysis 200
31 Bailey Instruments Ltd. Company Profile 205
31.1 Company Overview 205
32 Biopeak Corporation Company Profile 206
32.1 Company Overview 206
33 Critical Signal Technologies Company Profile 207
33.1 Company Overview 207
34 DexCom, Inc. Company Profile 208
34.1 Company Overview 208
35 EKF-diagnostic GmbH Company Profile 209
35.1 Company Overview 209
36 Epinex Diagnostics Incorporated Company Profile 210
36.1 Company Overview 210
36.2 Epinex Diagnostics Incorporated Pipeline Products 210
37 Foster-Miller, Inc. Company Profile 213
37.1 Company Overview 213
37.2 Foster-Miller, Inc. Pipeline Products 213
38 Freedom Meditech, Inc. Company Profile 215
38.1 Company Overview 215
39 GlucoLight Corporation Company Profile 216
39.1 Company Overview 216
40 Glucoplus Inc. Company Profile 217
40.1 Company Overview 217
41 GlySens Incorporated Company Profile 218
41.1 Company Overview 218
42 Financial Deals Landscape 219
42.1 Detailed Deal Summary 219
43 Recent Developments 239
43.1 Product News 239
44 Appendix 246
44.1 Global Markets Direct Research Methodology 246
44.2 Coverage 247
44.3 Secondary Research 247
44.4 Primary Research 248
44.5 Models 248
44.6 Forecasts 249
44.7 Expert Panels 249
44.8 Currency Conversion 250
44.9 Contact Us 251
44.10 Disclaimer 251

Executive Summary

1.1 List of Tables
Table 1: Global Diabetes Care Devices, Overall Revenues ($ mn), 2000-2012 26
Table 2: Global Diabetes Care Devices Market, Portfolio Analysis, 2000-2012 27
Table 3: Global Diabetes Care Devices, Overall Revenues ($ mn), Historic, 2000-2007 28
Table 4: Global Diabetes Care Devices, Overall Revenues ($ mn), Forecast, 2007-2012 29
Table 5: Global Diabetes Care Devices, Category Volume (Units), 2000-2012 30
Table 6: Global Diabetes Care Devices, Category Volume (Units), Historic, 2000-2007 31
Table 7: Global Diabetes Care Devices, Category Volume (Units), Forecast, 2007-2012 32
Table 8: Global Diabetes Care Devices, Company share (%), 2007 33
Table 9: Diabetes Care Devices Cross Country Comparison (2000-2012) 34
Table 10: Diabetes Care Devices, United States, Overall Revenues ($ mn), 2000-2012 35
Table 11: Diabetes Care Devices Market, United States, Portfolio Analysis, 2000-2012 36
Table 12: Diabetes Care Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007 37
Table 13: Diabetes Care Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012 38
Table 14: Diabetes Care Devices, United States, Category Volume (Units), 2000-2012 39
Table 15: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2000-2007 40
Table 16: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2007-2012 41
Table 17: Glucose Monitoring, United States, Distribution Share by Revenue ($mn), 2006-2007 42
Table 18: Insulin Delivery, United States, Distribution Share by Revenue ($mn), 2006-2007 42
Table 19: Diabetes Care Devices, United States, Company Share by Revenue ($ mn), 2006-2007 43
Table 20: Glucose Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 44
Table 21: Insulin Delivery, United States, Company Share by Revenue ($ mn), 2006-2007 45
Table 22: Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012 46
Table 23: Diabetes Care Devices Market, Canada, Portfolio Analysis, 2000-2012 47
Table 24: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007 48
Table 25: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 49
Table 26: Diabetes Care Devices, Canada, Category Volume (Units), 2000-2012 50
Table 27: Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2007 51
Table 28: Diabetes Care Devices, Canada, Category Volume (Units), Forecast, 2007-2012 52
Table 29: Glucose Monitoring, Canada, Distribution Share by Revenue ($mn), 2006-2007 53
Table 30: Insulin Delivery, Canada, Distribution Share by Revenue ($mn), 2006-2007 53
Table 31: Diabetes Care Devices, Canada, Company Share by Revenue ($ mn), 2006-2007 54
Table 32: Glucose Monitoring, Canada, Company Share by Revenue ($ mn), 2006-2007 55
Table 33: Insulin Delivery, Canada, Company Share by Revenue ($ mn), 2006-2007 56
Table 34: Diabetes Care Devices, Germany, Overall Revenues ($ mn), 2000-2012 57
Table 35: Diabetes Care Devices Market, Germany, Portfolio Analysis, 2000-2012 58
Table 36: Diabetes Care Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 59
Table 37: Diabetes Care Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 60
Table 38: Diabetes Care Devices, Germany, Category Volume (Units), 2000-2012 61
Table 39: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2007 62
Table 40: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2007-2012 63
Table 41: Glucose Monitoring, Germany, Distribution Share by Revenue ($mn), 2006-2007 64
Table 42: Insulin Delivery, Germany, Distribution Share by Revenue ($mn), 2006-2007 64
Table 43: Diabetes Care Devices, Germany, Company Share by Revenue ($ mn), 2006-2007 65
Table 44: Glucose Monitoring, Germany, Company Share by Revenue ($ mn), 2006-2007 66
Table 45: Insulin Delivery, Germany, Company Share by Revenue ($ mn), 2006-2007 67
Table 46: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012 68
Table 47: Diabetes Care Devices Market, France, Portfolio Analysis, 2000-2012 69
Table 48: Diabetes Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 70
Table 49: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012 71
Table 50: Diabetes Care Devices, France, Category Volume (Units), 2000-2012 72
Table 51: Diabetes Care Devices, France, Category Volume (Units), Historic, 2000-2007 73
Table 52: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2007-2012 74
Table 53: Glucose Monitoring, France, Distribution Share by Revenue ($mn), 2006-2007 75
Table 54: Insulin Delivery, France, Distribution Share by Revenue ($mn), 2006-2007 75
Table 55: Diabetes Care Devices, France, Company Share by Revenue ($ mn), 2006-2007 76
Table 56: Glucose Monitoring, France, Company Share by Revenue ($ mn), 2006-2007 77
Table 57: Insulin Delivery, France, Company Share by Revenue ($ mn), 2006-2007 78
Table 58: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 79
Table 59: Diabetes Care Devices Market, United Kingdom, Portfolio Analysis, 2000-2012 80
Table 60: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 81
Table 61: Diabetes Care Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 82
Table 62: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2012 83
Table 63: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007 84
Table 64: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012 85
Table 65: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($mn), 2006-2007 86
Table 66: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($mn), 2006-2007 86
Table 67: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 87
Table 68: Glucose Monitoring, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 88
Table 69: Insulin Delivery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 89
Table 70: Diabetes Care Devices, Italy, Overall Revenues ($ mn), 2000-2012 90
Table 71: Diabetes Care Devices Market, Italy, Portfolio Analysis, 2000-2012e 91
Table 72: Diabetes Care Devices, Italy, Overall Revenues ($ mn), Historic, 2000-2007 92
Table 73: Diabetes Care Devices, Italy, Overall Revenues ($ mn), Forecast, 2007-2012 93
Table 74: Diabetes Care Devices, Italy, Category Volume (Units), 2000-2012 94
Table 75: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2000-2007 95
Table 76: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2007-2012 96
Table 77: Glucose Monitoring, Italy, Distribution Share by Revenue ($mn), 2006-2007 97
Table 78: Insulin Delivery, Italy, Distribution Share by Revenue ($mn), 2006-2007 97
Table 79: Diabetes Care Devices, Italy, Company Share by Revenue ($ mn), 2006-2007 98
Table 80: Glucose Monitoring, Italy, Company Share by Revenue ($ mn), 2006-2007 99
Table 81: Insulin Delivery, Italy, Company Share by Revenue ($ mn), 2006-2007 100
Table 82: Diabetes Care Devices, Spain, Overall Revenues ($ mn), 2000-2012 101
Table 83: Diabetes Care Devices Market, Spain, Portfolio Analysis, 2000-2012 102
Table 84: Diabetes Care Devices, Spain, Overall Revenues ($ mn), Historic, 2000-2007 103
Table 85: Diabetes Care Devices, Spain, Overall Revenues ($ mn), Forecast, 2007-2012 104
Table 86: Diabetes Care Devices, Spain, Category Volume (Units), 2000-2012 105
Table 87: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2000-2007 106
Table 88: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2007-2012 107
Table 89: Glucose Monitoring, Spain, Distribution Share by Revenue ($mn), 2006-2007 108
Table 90: Insulin Delivery, Spain, Distribution Share by Revenue ($mn), 2006-2007 108
Table 91: Diabetes Care Devices, Spain, Company Share by Revenue ($ mn), 2006-2007 109
Table 92: Glucose Monitoring, Spain, Company Share by Revenue ($ mn), 2006-2007 110
Table 93: Insulin Delivery, Spain, Company Share by Revenue ($ mn), 2006-2007 111
Table 94: Diabetes Care Devices, Japan, Overall Revenues ($ mn), 2000-2012 112
Table 95: Diabetes Care Devices Market, Japan, Portfolio Analysis, 2000-2012 113
Table 96: Diabetes Care Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007 114
Table 97: Diabetes Care Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012 115
Table 98: Diabetes Care Devices, Japan, Category Volume (Units), 2000-2012 116
Table 99: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2000-2007 117
Table 100: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2007-2012 118
Table 101: Glucose Monitoring, Japan, Distribution Share by Revenue ($mn), 2006-2007 119
Table 102: Insulin Delivery, Japan, Distribution Share by Revenue ($mn), 2006-2007 119
Table 103: Diabetes Care Devices, Japan Company share by Revenue ($ mn), 2006-2007 120
Table 104: Glucose Monitoring, Japan, Company Share by Revenue ($ mn), 2006-2007 121
Table 105: Insulin Delivery, Japan, Company Share by Revenue ($ mn), 2006-2007 122
Table 106: Diabetes Care Devices, China, Overall Revenues ($ mn), 2000-2012 123
Table 107: Diabetes Care Devices Market, China, Portfolio Analysis, 2000-2012 124
Table 108: Diabetes Care Devices, China, Overall Revenues ($ mn), Historic, 2000-2007 125
Table 109: Diabetes Care Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012 126
Table 110: Diabetes Care Devices, China, Category Volume (Units), 2000-2012 127
Table 111: Diabetes Care Devices, China, Category Volume (Units), Historic, 2000-2007 128
Table 112: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2007-2012 129
Table 113: Glucose Monitoring, China, Distribution Share by Revenue ($mn), 2006-2007 130
Table 114: Insulin Delivery, China, Distribution Share by Revenue ($mn), 2006-2007 130
Table 115: Diabetes Care Devices, China, Company Share by Revenue ($ mn), 2006-2007 131
Table 116: Glucose Monitoring, China, Company Share by Revenue ($ mn), 2006-2007 132
Table 117: Insulin Delivery, China, Company Share by Revenue ($ mn), 2006-2007 133
Table 118: Diabetes Care Devices, India, Overall Revenues ($ mn), 2000-2012 134
Table 119: Diabetes Care Devices Market, India, Portfolio Analysis, 2000-2012 135
Table 120: Diabetes Care Devices, India, Overall Revenues ($ mn), Historic, 2000-2007 136
Table 121: Diabetes Care Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012 137
Table 122: Diabetes Care Devices, India, Category Volume (Units), 2000-2012 138
Table 123: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2007 139
Table 124: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2007-2012 140
Table 125: Glucose Monitoring, India, Distribution Share by Revenue ($mn), 2006-2007 141
Table 126: Insulin Delivery, India, Distribution Share by Revenue ($mn), 2006-2007 141
Table 127: Diabetes Care Devices, India Company share by Revenue ($ mn), 2006-2007 142
Table 128: Glucose Monitoring, India, Company Share by Revenue ($ mn), 2006-2007 143
Table 129: Insulin Delivery, India, Company Share by Revenue ($ mn), 2006-2007 144
Table 130: Diabetes Care Devices, Australia, Overall Revenues ($ mn), 2000-2012 145
Table 131: Diabetes Care Devices Market, Australia, Portfolio Analysis, 2000-2012 146
Table 132: Diabetes Care Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007 147
Table 133: Diabetes Care Devices, Australia, Overall Revenues ($ mn), Forecast, 2007-2012 148
Table 134: Diabetes Care Devices, Australia, Category Volume (Units), 2000-2012 149
Table 135: Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2000-2007 150
Table 136: Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2007-2012 151
Table 137: Glucose Monitoring, Australia, Distribution Share by Revenue ($mn), 2006-2007 152
Table 138: Insulin Delivery, Australia, Distribution Share by Revenue ($mn), 2006-2007 152
Table 139: Diabetes Care Devices, Australia, Company Share by Revenue ($ mn), 2006-2007 153
Table 140: Glucose Monitoring, Australia, Company Share by Revenue ($ mn), 2006-2007 154
Table 141: Insulin Delivery, Australia, Company Share by Revenue ($ mn), 2006-2007 155
Table 142: Diabetes Care Devices, Brazil, Overall Revenues ($ mn), 2000-2012 156
Table 143: Diabetes Care Devices Market, Brazil, Portfolio Analysis, 2000-2012 157
Table 144: Diabetes Care Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 158
Table 145: Diabetes Care Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 159
Table 146: Diabetes Care Devices, Brazil, Category Volume (Units), 2000-2012 160
Table 147: Diabetes Care Devices, Brazil, Category Volume (Units), Historic, 2000-2007 161
Table 148: Diabetes Care Devices, Brazil, Category Volume (Units), Forecast, 2007-2012 162
Table 149: Glucose Monitoring, Brazil, Distribution Share by Revenue ($mn), 2006-2007 163
Table 150: Insulin Delivery, Brazil, Distribution Share by Revenue ($mn), 2006-2007 163
Table 151: Diabetes Care Devices, Brazil Company share by Revenue ($ mn), 2006-2007 164
Table 152: Glucose Monitoring, Brazil, Company Share by Revenue ($ mn), 2006-2007 165
Table 153: Insulin Delivery, Brazil, Company Share by Revenue ($ mn), 2006-2007 166
Table 154: LifeScan, Inc. Pipeline Products by Equipment Type 170
Table 155: LifeScan, Inc. Pipeline Products by Equipment Type 170
Table 156: LifeScan, Inc. Pipeline Products By Therapy Area 170
Table 157: LifeScan, Inc. Pipeline Products By Clinical Trials 170
Table 158: LifeScan, Inc. Pipeline Products By News Summaries 171
Table 159: Abbott Laboratories Pipeline Products by Equipment Type 174
Table 160: Abbott Laboratories Pipeline Products By Development Stage 174
Table 161: Abbott Laboratories Pipeline Products By Therapy Area 175
Table 162: Abbott Laboratories Pipeline Products By Clinical Trials 175
Table 163: Abbott Laboratories Pipeline Products By News Summaries 175
Table 164: Novo Nordisk A/S Pipeline Products by Equipment Type 176
Table 165: Novo Nordisk A/S Pipeline Products By Development Stage 176
Table 166: Novo Nordisk A/S Pipeline Products By Therapy Area 176
Table 167: Novo Nordisk A/S Pipeline Products By Clinical Trials 177
Table 168: Bayer HealthCare AG Pipeline Products by Equipment Type 180
Table 169: Bayer HealthCare AG Pipeline Products By Development Stage 180
Table 170: Bayer HealthCare AG Pipeline Products By Therapy Area 181
Table 171: Bayer HealthCare AG Pipeline Products By News Summaries 181
Table 172: Eli Lilly and Company Pipeline Products by Equipment Type 184
Table 173: Eli Lilly and Company Pipeline Products by Development Stage 185
Table 174: Eli Lilly and Company Pipeline Products By Therapy Area 185
Table 175: Medtronic, Inc. Pipeline Products by Equipment Type 188
Table 176: Medtronic, Inc. Pipeline Products By Development Stage 190
Table 177: Medtronic, Inc. Pipeline Products By Therapy Area 192
Table 178: Medtronic, Inc. Pipeline Products By Clinical Trials 194
Table 179: Medtronic, Inc. Pipeline Products By News Summaries 195
Table 180: ARKRAY, Inc. Pipeline Products by Equipment Type 198
Table 181: ARKRAY, Inc. Pipeline Products By Development Stage 198
Table 182: ARKRAY, Inc. Pipeline Products By News Summaries 198
Table 183: Terumo Corporation Pipeline Products by Equipment Type 201
Table 184: Terumo Corporation Pipeline Products By Development Stage 201
Table 185: Terumo Corporation Pipeline Products By Therapy Area 201
Table 186: Terumo Corporation Pipeline Products By Clinical Trials 201
Table 187: Terumo Corporation Pipeline Products By News Summaries 202
Table 188: AgaMatrix, Inc. Pipeline Products by Equipment Type 203
Table 189: AgaMatrix, Inc. Pipeline Products by Development Stage 203
Table 190: AgaMatrix, Inc. Pipeline Products By Therapy Area 203
Table 191: B. Braun Melsungen AG Pipeline Products by Equipment Type 208
Table 192: B. Braun Melsungen AG Pipeline Products By Development Stage 208
Table 193: B. Braun Melsungen AaG Pipeline Products By Therapy Area 208
Table 194: B. Braun Melsungen AG Pipeline Products By Clinical Trials 209
Table 195: B. Braun Melsungen AG Pipeline Products By News Summaries 209
Table 196: Critical Signal Technologies Pipeline Products by Equipment Type 212
Table 197: Critical Signal Technologies Pipeline Products by Development Stage 212
Table 198: Critical Signal Technologies Pipeline Products By Therapy Area 212
Table 199: DexCom, Inc. Pipeline Products by Equipment Type 213
Table 200: DexCom, Inc. Pipeline Products By Development Stage 213
Table 201: DexCom, Inc. Pipeline Products By Therapy Area 213
Table 202: DexCom, Inc. Pipeline Products By News Summaries 213
Table 203: Epinex Diagnostics Incorporated Pipeline Products by Equipment Type 215
Table 204: Epinex Diagnostics Incorporated Pipeline Products By Development Stage 216
Table 205: Epinex Diagnostics Incorporated Pipeline Products By Therapy Area 217
Table 206: Epinex Diagnostics Incorporated Pipeline Products By News Summaries 217
Table 207: Foster-Miller, Inc. Pipeline Products by Equipment Type 218
Table 208: Foster-Miller, Inc. Pipeline Products By Development Stage 218
Table 209: Foster-Miller, Inc. Pipeline Products By Therapy Area 219
Table 210: Foster-Miller, Inc. Pipeline Products By Clinical Trials 219
Table 211: Freedom Meditech, Inc. Pipeline Products by Equipment Type 220
Table 212: Freedom Meditech, Inc. Pipeline Products By Development Stage 220
Table 213: Freedom Meditech, Inc. Pipeline Products By Therapy Area 220
Table 214: GlucoLight Corporation Pipeline Products by Equipment Type 221
Table 215: GlucoLight Corporation Pipeline Products by Development Stage 221
Table 216: GlucoLight Corporation Pipeline Products By Therapy Area 221
Table 217: GlucoLight Corporation Pipeline Products By News Summaries 221
Table 218: GlySens Incorporated Pipeline Products by Equipment Type 223
Table 219: GlySens Incorporated Pipeline Products by Development Stage 223
Table 220: The Blackstone Group Acquires Apria Healthcare 224
Table 221: Valeritas Secures $50 Million In Financing 226
Table 222: Freedom Meditech Secures $0.38 Million In Series A Financing 227
Table 223: ArKal Medical Secures $17.5 Million In Series B Financing 228
Table 224: GluMetrics Secures $20.08 Million In Series C Financing 229
Table 225: Calibra Medical Secures $35 Million In Series B Financing 230
Table 226: Tandem Diabetes Care Secures $13.05 Million In Series B Financing 231
Table 227: VeraLight Secures $20 Million In Series C Financing 232
Table 228: DexCom Files For Public Offering Of $40 Million 234
Table 229: Biosign Technologies Announces Private Placement Of $1.89 Million 235
Table 230: CCS Medical Holdings Terminates Its Initial Public Offering 237
Table 231: XTend Medical Completes Public Offering Of $1 Million 238
Table 232: Insulet Completes Private Placement Of $85 Million 239
Table 233: Edwards Lifesciences Enters Into An Agreement With DexCom 241
Table 234: Oxygen Biotherapeutics Enters Into An Agreement With Glucometrics 242
Table 235: XTend Medical Enters Into An Agreement With Diabetes Detection 243
Table 236: Currency Conversion from USD to Local Currency at 2007 Constant Rate 255


Companies Mentioned F. Hoffmann-La Roche Ltd. LifeScan, Inc. Abbott Laboratories Novo Nordisk A/S Bayer HealthCare AG Eli Lilly and Company Medtronic, Inc. Becton, Dickinson and Company ARKRAY, Inc. Terumo Corporation AgaMatrix, Inc. Animas Corporation B. Braun Melsungen AG Bailey Instruments Ltd. Biopeak Corporation Critical Signal Technologies DexCom, Inc. EKF-diagnostic GmbH Epinex Diagnostics Incorporated Foster-Miller, Inc. Freedom Meditech, Inc. GlucoLight Corporation Glucoplus Inc. GlySens Incorporated


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/679425

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 29/11/2009 04:24:58
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

Web Address:
http://www.researchandmarkets.com/reports/679425

Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,686.00
Electronic (PDF) - Site License €5,373.00
Electronic (PDF) - Enterprisewide €8,059.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 29/11/2009 04:24:58


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)